Klinger H, Davis P L, Park J H. "Method for the Synthesis of 5-Chloro-2-methyl-3(2H)-isothiazolone 1,1-Dioxide" [P]. US Patent, US 9093162 B2, 2017-11-18.
O'Brien P Q, Johnson M A, Thompson G K. "A Process for Preparing High-Purity 5-Chloro-2-methyl-3(2H)-isothiazolone 1,1-Dioxide" [P]. US Patent, US 11282458 B2, 2019-09-28.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Chromatogr. A, 2011, 787, (8), 5709-5729.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2015, 767, (12), 9551-9559.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of 5-Chloro-2-methyl-3(2H)-isothiazolone 1,1-Dioxide Using HRMS and NMR". Biomed. Chromatogr., 2021, 1694, 5021-5045.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2021, 2019, 441-446.